Table 2 Patient characteristics
Lotus (n = 53) | Sapien (n = 47) | p-value | |
|---|---|---|---|
Age (years) | 84.1 (4.9) | 77.1 (11.5) | 0.0001 |
Male | 35.8% (19) | 53.2% (25) | 0.1068 |
Diabetes mellitus | 15.1% (8) | 25.5% (12) | 0.2186 |
COPD | 7.5% (4) | 17% (8) | 0.2179 |
Hypertension | 77.4% (41) | 80.9% (38) | 0.8067 |
Recent myocardial infarction | 15.1% (8) | 6.4% (3) | 0.2096 |
Previous stroke | 17% (9) | 25.5% (12) | 0.3327 |
Peripheral vascular disease | 15.1% (8) | 14.9% (7) | 1.0000 |
Atrial fibrillation | 43.4% (23) | 25.5% (12) | 0.0923 |
Pre-op dialysis | 0% (0) | 2.1% (1) | 0.4700 |
Previous cardiac surgery | 22.6% (12) | 19.1% (9) | 0.8067 |
Previous PCI | 20.8% (11) | 27.7% (13) | 0.4855 |
NYHA I | 0% (0) | 0% (0) | |
NYHA II | 5.7% (3) | 14.9% (7) | 0.1831 |
NYHA III | 71.7% (38) | 76.6% (36) | 0.6513 |
NYHA IV | 22.6% (12) | 8.5% (4) | 0.0619 |
Denied surgical AVR | 60.4% (32) | 76.6% (36) | 0.0912 |
Pre-op creatinine mmol/L | 101.1 (42.2) | 109.2 (63.6) | 0.4542 |
EuroSCORE I | 25.3 (12.3) | 18,2 (10.7) | 0.0030 |
EuroSCORE II | 7.8 (4.6) | 5.8 (4.8) | 0.0378 |
STS score | 7.1 (4.4) | 6.3 (7.5) | 0.4880 |
Valve-in-Valve | 0% (0) | 6.4% (3) | 0.1003 |